Literature DB >> 16238580

Intervention during pregnancy and allergic disease in the offspring.

S Salvatore1, K Keymolen, B Hauser, Y Vandenplas.   

Abstract

The etiology of allergy is multifactorial, with many variables contributing to the final expression of atopic disease. Three breeding grounds are needed to develop allergic disease: the appropriate genetic background, contact with the allergen(s) and environmental factors. Timing and dosing of allergen(s) are of major importance. Contact with (dietary) allergens and various agents such as tobacco smoke and infections occur not only during post-natal life, but also perinatally and even pre-natally. A critical review of published evidence regarding the impact of maternal exposure to antigens during pregnancy on later development of allergy in the offspring can only conclude that more research is urgently needed. Contact with multiple dietary allergens should be in general of benefit to the fetus to develop tolerance. Current knowledge suggests that pregnant women should have a normal diversified diet, avoiding toxic agents such as tobacco and alcohol. The role of maternal intake of poly-unsaturated fatty acids on the development of atopy in the infants needs to be further evaluated. If parental history would be insufficient to determine the fetal risk, preventive measurements would be advisable for all fetuses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16238580     DOI: 10.1111/j.1399-3038.2005.00315.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  3 in total

Review 1.  Update on allergies in pregnancy, lactation, and early childhood.

Authors:  Isabella Pali-Schöll; Harald Renz; Erika Jensen-Jarolim
Journal:  J Allergy Clin Immunol       Date:  2009-02-26       Impact factor: 10.793

2.  Asthma and allergic diseases in pregnancy a review.

Authors:  Isabella Pali-Schöll; Cassim Motala; Erika Jensen-Jarolim
Journal:  World Allergy Organ J       Date:  2009-03       Impact factor: 4.084

3.  10-year experience with umbilical cord blood IgE and microbiome therapy.

Authors:  Jiří Liška; Konrad Siala; Blanka Čuláková; Václav Holeček; Štěpánka Sobotová; Josef Sýkora; František Šefrna
Journal:  Ital J Pediatr       Date:  2019-03-11       Impact factor: 2.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.